title: Modeling hypertrophic IP3 transients in the cardiac myocyte.
abstract: Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we construct a mathematical model of the IP3 signal production system after stimulation by a hypertrophic alpha-adrenergic agonist (endothelin-1) in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to precoupled (with G(alpha)GDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated with the receptor system contribute to the behavior of the system to a great extent, with precoupled receptors driving the response to extracellular ligand. Finally, by reparameterizing for a second hypertrophic alpha-adrenergic agonist, angiotensin-II, we show that differences in key receptor kinetic and membrane density parameters are sufficient to explain different observed IP3 transients in essentially the same pathway.
authors: Auckland Bioengineering Institute, Department of Engineering Science, University of Auckland, New Zealand. m.cooling@auckland.ac.nz
authors: Michael
authors: M
authors: Cooling
authors: Peter
authors: P
authors: Hunter
authors: Edmund J
authors: EJ
authors: Crampin
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D019332:Endothelin-1 / Q000378:metabolism; D005289:Ferrets; D015544:Inositol 1,4,5-Trisphosphate / Q000737:chemistry*; D008954:Models, Biological; D008962:Models, Theoretical; D032383:Myocytes, Cardiac / Q000378:metabolism*; D054799:Phospholipase C beta / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D000316:Adrenergic alpha-Agonists; D019332:Endothelin-1; D043562:Receptors, G-Protein-Coupled; D000804:Angiotensin II; D015544:Inositol 1,4,5-Trisphosphate; D054799:Phospholipase C beta
references: J Biol Chem. 2000 Jun 9;275(23):17596-604
references: 10747877
references: Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
references: 16870827
references: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):2947-9
references: 11248009
references: J Biol Chem. 2001 Apr 20;276(16):13096-103
references: 11150299
references: Circ Res. 2001 Jun 22;88(12):1239-46
references: 11420299
references: Cell. 2002 Apr;109 Suppl:S67-79
references: 11983154
references: J Physiol. 2002 May 15;541(Pt 1):1-8
references: 12015416
references: Circ Res. 2002 May 31;90(10):1055-63
references: 12039794
references: EMBO J. 2003 Jan 2;22(1):131-9
references: 12505991
references: Bioinformatics. 2003 Feb 12;19(3):408-15
references: 12584128
references: J Cell Biol. 2003 May 26;161(4):779-91
references: 12771127
references: Prog Cell Cycle Res. 2003;5:219-24
references: 14593716
references: Chin Med J (Engl). 2004 Jan;117(1):88-93
references: 14733781
references: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1124-32
references: 14630640
references: Exp Physiol. 2004 Jan;89(1):1-26
references: 15109205
references: Prog Biophys Mol Biol. 2004 Jun-Jul;85(2-3):433-50
references: 15142756
references: Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91
references: 15336966
references: Biophys J. 2004 Sep;87(3):1406-16
references: 15345523
references: Nature. 1991 Apr 11;350(6318):516-8
references: 1707501
references: Circ Res. 1991 Sep;69(3):800-9
references: 1651818
references: J Pharmacol Exp Ther. 1992 Sep;262(3):1189-94
references: 1326626
references: Circ Res. 1993 Sep;73(3):424-38
references: 8348687
references: Cell. 1993 Dec 3;75(5):977-84
references: 8252633
references: Circ Res. 1996 Apr;78(4):724-36
references: 8635230
references: Biochem Pharmacol. 1997 Feb 21;53(4):519-30
references: 9105403
references: J Biol Chem. 1997 Jul 11;272(28):17734-43
references: 9211925
references: Biochemistry. 1997 Oct 28;36(43):13325-32
references: 9341224
references: J Biol Chem. 1998 Feb 27;273(9):5037-46
references: 9478953
references: Gen Pharmacol. 1998 Mar;30(3):367-72
references: 9510088
references: Circulation. 1998 Mar 10;97(9):892-9
references: 9521338
references: Cell. 1998 Apr 17;93(2):215-28
references: 9568714
references: Braz J Med Biol Res. 2002 Sep;35(9):1001-15
references: 12219172
references: Life Sci. 1998;62(17-18):1561-5
references: 9585136
references: Science. 1999 Jan 15;283(5400):381-7
references: 9888852
references: Cell. 1999 Mar 5;96(5):611-4
references: 10089876
references: Circ Res. 1999 Apr 2;84(6):633-46
references: 10189351
references: Am J Physiol. 1999 Apr;276(4 Pt 2):H1197-206
references: 10199843
references: J Mol Cell Cardiol. 1999 May;31(5):949-70
references: 10336836
references: Proc Soc Exp Biol Med. 2000 Jan;223(1):53-8
references: 10632961
references: Z Kardiol. 2000 Jan;89(1):1-6
references: 10663910
references: J Clin Invest. 2000 May;105(10):1395-406
references: 10811847
references: J Biol Chem. 2005 Apr 22;280(16):15912-20
references: 15710625
references: J Biol Chem. 2006 Jan 6;281(1):608-16
references: 16249182
references: Biophys J. 2006 May 1;90(9):3074-90
references: 16473911
references: Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600
references: 16936699
references: Biotechnol Bioeng. 2000 Oct 20;70(2):225-38
references: 10972934